SCHEMBL6840596

SCHEMBL6840596

NCc1cccc(C2(C(=O)Nc3ccc(N4CCCCC4=O)cc3)CCCC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.46
TSHR P16473 2/20 0.46
HPGD P15428 1/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
ALDH1A1 P00352 1/20 0.45
TP53 P04637 1/20 0.45
GLA P06280 1/20 0.45
PKM P14618 1/20 0.45
F10 P00742 5/20 0.44
KDM1A O60341 1/20 0.43
MAOB P27338 1/20 0.43
MAPT P10636 2/20 0.43
GAA P10253 2/20 0.42
BACE1 P56817 1/20 0.41
NAMPT P43490 1/20 0.41
CDK2 P24941 1/20 0.41
PRSS1 P07477 1/20 0.41
PRSS2 P07478 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6839757 0.85 LMNA (0.44) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL6840749 0.85 LMNA (0.44) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL6840741 0.85 LMNA (0.44) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL6840564 0.84 LMNA (0.45) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL6840565 0.84 LMNA (0.45) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL5164898 0.81 SMN1; SMN2 (0.52) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL5164789 0.80 TSHR (0.48) LMNATSHRHPGDSMN1; SMN2NPC1
SCHEMBL27585029 0.78 F10 (0.44) LMNATSHRHPGDNPC1RAB9A
SCHEMBL27585019 0.77 F10 (0.44) LMNATSHRHPGDNPC1RAB9A
SCHEMBL6840555 0.75 KDM1A (0.55) LMNATSHRHPGDSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082563-A1 Phenyl derivatives 3 MERCK PATENT GMBH (DE) 2004-04-29 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082563-A1 Phenyl derivatives 3 F2, F11, F12 LMNA 910/4885TSHR 484/4885HPGD 672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.